Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Dow
Moodys
Colorcon
McKinsey

Last Updated: May 26, 2022

VENTOLIN HFA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Ventolin Hfa patents expire, and when can generic versions of Ventolin Hfa launch?

Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-nine patent family members in seventeen countries.

The generic ingredient in VENTOLIN HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

Drug patent expirations by year for VENTOLIN HFA
Drug Prices for VENTOLIN HFA

See drug prices for VENTOLIN HFA

Drug Sales Revenue Trends for VENTOLIN HFA

See drug sales revenues for VENTOLIN HFA

Recent Clinical Trials for VENTOLIN HFA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State UniversityPhase 4
Nationwide Children's HospitalPhase 4
Ziauddin UniversityPhase 1

See all VENTOLIN HFA clinical trials

US Patents and Regulatory Information for VENTOLIN HFA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 BX RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 BX RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VENTOLIN HFA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 See Plans and Pricing See Plans and Pricing
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 See Plans and Pricing See Plans and Pricing
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 See Plans and Pricing See Plans and Pricing
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 See Plans and Pricing See Plans and Pricing
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 See Plans and Pricing See Plans and Pricing
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VENTOLIN HFA

See the table below for patents covering VENTOLIN HFA around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 1287820 Compositions d'aérosol (Aerosol compositions) See Plans and Pricing
Germany 69233076 See Plans and Pricing
Estonia 9700280 See Plans and Pricing
United Kingdom 0017301 See Plans and Pricing
Bulgaria 98803 See Plans and Pricing
Czech Republic 292578 Inhalátor, inhalační systém (Inhalator, inhalation system) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Boehringer Ingelheim
McKesson
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.